Despite record numbers of drug shortages being reported in the US, on the whole, over the past five years the supply of these drugs to healthcare providers–hospitals, clinics, pharmacies–has increased, according to a new report published by IMS Institute for Healthcare Informatics.
In fact, for over half of the drugs on the shortages list, total supply is relatively stable or has increased over the past five years. However, there has been a dramatic decline in the total supply available for the remaining drugs on the shortages list, see Figure 1.
Figure 1: Variation of supply for drugs on the shortages list in the US
Source: IMS Institute for Healthcare Informatics.
Among the 168 drugs on the drug shortages list maintained by FDA and American Society of Health-System Pharmacists (ASHP) as of 7 October 2011, three distinct supply patterns have emerged during the three months ending August 2011 compared to the average monthly volume in 2006–09:
Spending for drugs on the shortages list has also increased. However, the market is now showing high volatility, with unusually sharp swings in supply for many of the drugs on the shortages list.
Within the different US states utilisation also varies significantly, with 13 states experiencing significant drops in supply.
Many believe that these swings and differences in supply and price may be due to the practice of hoarding of essential drugs on the shortages list and the subsequent grey market, which also results in inflated prices for drugs in short supply.
Source URL: https://gabi-journal.net/news/volume-and-sales-of-drugs-on-the-shortages-list-in-the-us
Copyright ©2022 GaBI Journal unless otherwise noted.